Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85% Market Closed
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kamada Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Total Other Income
-$2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Total Other Income
-$10k
CAGR 3-Years
31%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Total Other Income
-$22.4m
CAGR 3-Years
-30%
CAGR 5-Years
-142%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Total Other Income
$566k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Kamada Ltd's Total Other Income?
Total Other Income
-2.9m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Total Other Income amounts to -2.9m USD.

Back to Top